title: Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneity.
abstract: It is important to understand HDL heterogeneity because various subspecies possess different functionalities. To understand the origins of HDL heterogeneity arising from the existence of particles containing only apoA-I (LpA-I) and particles containing both apoA-I and apoA-II (LpA-I+A-II), we compared the abilities of both proteins to promote ABCA1-mediated efflux of cholesterol from HepG2 cells and form nascent HDL particles. When added separately, exogenous apoA-I and apoA-II were equally effective in promoting cholesterol efflux, although the resultant LpA-I and LpA-II particles had different sizes. When apoA-I and apoA-II were mixed together at initial molar ratios ranging from 1:1 to 16:1 to generate nascent LpA-I+A-II HDL particles, the particle size distribution altered, and the two proteins were incorporated into the nascent HDL in proportion to their initial ratio. Both proteins formed nascent HDL particles with equal efficiency, and the relative amounts of apoA-I and apoA-II incorporation were driven by mass action. The ratio of lipid-free apoA-I and apoA-II available at the surface of ABCA1-expressing cells is a major factor in determining the contents of these proteins in nascent HDL. Manipulation of this ratio provides a means of altering the relative distribution of LpA-I and LpA-I+A-II HDL particles.
authors.affiliation: GI/Nutrition/Hepatology Division, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
authors.forename: Eric T
authors.initials: ET
authors.lastname: Alexander
authors.forename: Michael C
authors.initials: MC
authors.lastname: Phillips
mesh_terms: D064286:ATP Binding Cassette Transporter 1 / Q000378:metabolism*; D016632:Apolipoprotein A-I / Q000494:pharmacology*; D016633:Apolipoprotein A-II / Q000494:pharmacology*; D008076:Cholesterol, HDL / Q000378:metabolism*; D056945:Hep G2 Cells; D006801:Humans; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D064286:ATP Binding Cassette Transporter 1; D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D008076:Cholesterol, HDL
keywords: ATP binding cassette A1; cholesterol; lipoprotein; phospholipid